Natural killer cells and immune surveillance

Jornal de Pediatria

Volumn 84, Issue 4 SUPPL., 2008, Pages

  Jobim, Mariana ^a,b   Jobim, Luiz Fernando J ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

KIR genes; KIR genotypes in Brazilian caucasoids; Natural killer cells

Indexed keywords

LEUKOCYTE ANTIGEN;

ALLELE; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; COMPARATIVE STUDY; DNA POLYMORPHISM; GENE; GENE IDENTIFICATION; GENOTYPE; HAPLOTYPE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSURVEILLANCE; KILLER IMMUNOGLOBULIN LIKE RECEPTOR GENE; NATURAL KILLER CELL; NOMENCLATURE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PSORIASIS VULGARIS; REVIEW; STEM CELL TRANSPLANTATION;

AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; BRAZIL; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; HAPLOTYPES; HEPATITIS C; HIV INFECTIONS; HUMANS; IMMUNOLOGIC SURVEILLANCE; KILLER CELLS, NATURAL; POLYMORPHISM, GENETIC; RECEPTORS, KIR;

EID: 57349196393     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.2223/JPED.1780     Document Type: Review

References (40)

1. Parham P. Taking license with natural killer cell maturation and repertoire development. Immunol Rev. 2006;214:155-60.
2. Parham P. The body's defenses against infection. In: Parham P, editors. The imune system. New York: Garland Science; 2005. p. 252-6.
3. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptative immunity. Annu Rev Immunol. 2002;20:217-51.
4. Ljunggren HG, Pääbo S, Cochet M, Kling G, Kourilsky P, Kärre K. Molecular analysis of H-2 deficient lymphoma lines. Distinct defects in biosynthesis and association of MHC class I heavy chains and beta 2-microglobulin observed in cells with increased sensitivity to NK cell lysis. J Immunol. 1989;142:2911-7.
5. Ljunggren HG, Karre K. In search of the "missing self": MHC molecules and NK cell recognition. Immunol Today. 1990;11:237-44.
6. Boyton RJ, Altmann DM. Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol. 2007;149:1-8.
7. Degli-Esposti MA, Smyth MJ. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol. 2005;5:112-24.
8. O'Connor GM, Hart OM, Gardiner CM. Putting the natural killer cell in its place. Immunology. 2006;117:1-10.
9. The Immuno Polimorphism Database. KIR database. http://www.ebi.ac.uk/ipd/ kir
10. André P, Biassoni R, Colonna M, Cosman D, Lanier LL, Long EO, et al. New nomenclature for MHC receptors. Nat Immunol. 2001;2:661.
11. Cook MA, Norman PJ, Curran MD, Maxwell LD, Briggs DC, Middleton D, et al. A multi-laboratory characterization of the KIR genotypes of 10th International Histocompatibility Workshop cell lines. Hum Immunol. 2003;64:567-71.
12. Hsu KC, Chida S, Geragthty DE, Dupont, B. Killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev. 2002;190:40-52.
13. Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol. 2002;169:5118-29.
14. Shilling HG, Guethlein LA, Cheng NW, Gardiner CM, Rodriguez R, Tyan D, et al. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J Immunol. 2002;168:239-47.
15. Biassoni R, Falco M, Cambiaggi A, Costa P, Verdiani S, Pende D, et al. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group2" or "group 1"NK clones. J Exp Med. 1995;182:605-9.
16. Cella M, Longo A, Ferrara GB, Strominger JL, Colonna M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucina 80. J Exp Med. 1994;180:1235-42.
17. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
18. Gomez-Lozano N, Vilches C. Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update. Tissue Antigens. 2002:59:184-93.
19. Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primers mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens. 1995;46:355-67.
20. Contreras G, Aláez C, Murguía A, Garcia D, Flores H, Gorodezky C. Distribution of the killer cell immunoglobulin-like receptors in Mexican Mestizos. Tissue Antigens. 2007;69 Suppl 1:125-9.
21. Flores, AC, Marcos CY, Paladino N, Capucchio M, Theiler G, Arruvito L, et al. KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations. Tissue Antigens. 2007:568-76.
22. Gutiérrez-Rodríguez ME, Sandoval-Ramírez L, Díaz-Flores M, Marsh SG, Valladares-Salgado A, Madrigal JA, et al. KIR gene in ethnic and mestizo population from Mexico. Hum Immunol. 2006,67:85-93
23. Norman PJ, Stephens HA, Verity DH, Chandanayingyong D, Vaughan RW. Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnics groups. Immunogenetics. 2001;52:195-205.
24. Jiang K, Zhu FM, Lv QF, Yan LX. Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. Tissue Antigens. 2005;65:556-63.
25. Yawata M, Yawata N, McQueen KL, Cheng NW, Guethlein LA, Rajalingam R, et al. Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression. Immunogenetics. 2002;54:543-50.
26. Toneva M, Lepage V, Lafay G, Dulphy N, Busson M, Lester S, et al. Genomic diversity of natural killer cell receptor genes in three populations. Tissue Antigens. 2001;57:358-62.
27. Valiante NM, Uhrberg M, Shilling HG, Lienert-Weidenbach K, Arnett KL, D'Andrea A, et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity. 1997;7:739-51.
28. Khakoo SI, Carrington M. KIR and disease: a model system or system of models. Immunol Rev. 2006;214:186-201.
29. Williams AP, Bateman AR, Khakoo, SI. Hanging in the balance: KIR and their role in disease. Mol Interv. 2005;5:226-40.
30. Kim S, Poursine-Laurent J, Truscott SM, Lybarger L, Song YJ, Yang L, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. 2005;436:709-13.
31. Flores-Villanueva PO, Yunis EJ, Delgado JC, Vittinghoff E, Buchbinder S, Leung JY, et al. Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc Natl Acad Sci USA. 2001;98:5140-5.
32. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet. 2002;31:429-34.
33. Jennes W, Verheyden S, Demanet C, Adjé-Touré C, Vuylsteke B, Nkengasong JN, et al. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol. 2006;177:6588-92.
34. Ruggeri L, Capanni M, Urbani E, Perruccio K, Shlomchik WD, Tosti A, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science. 2002;295:2097-100.
35. McQueen KL, Dorighi KM, Guethlein LA, Wong R, Sanjanwala B, Parham P. Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation. Hum Immunol. 2007;68:309-23.
36. Momot T, Koch S, Hunzelmann N, Krieg T, Ulbricht K, Schmidt RE, et al. Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum. 2004;50:1561-5.
37. Pellett F, Siannis F, Vukin I, Urowitz MB, Gladman D. KIRs and autoimmune disease: studies in systemic lupus erythematosus and scleroderma. Tissue Antigens. 2007; 69: 106-108.
38. Nelson GW, Martin MP, Gladman D, Wade J, Trowsdale J, Carrington M. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol. 2004;173:4273-6.
39. van der Slik AR, Alizadeh BZ, Koeleman BP, Roep BO, Giphart MJ. Modelling KIR-HLA genotype disparities in type I diabetes. Tissue Antigens. 2007;69:101-5.
40. Bashirova AA, Martin MP, McVicar DW, Carrington M. The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu Rev Genomics Hum Genet. 2006;7:277-300.